経頸部女性の不妊手術市場2020：地域の見通し（アメリカ、ヨーロッパ、アジア太平洋、中東、アフリカ）別のサイズ、業界分析レポート、成長の可能性、価格動向、競争力のある市場シェア、市場統計と予測2020-2025 (アップデート版あり)

このレポートには、最新の市場図、統計、データが含まれています

ライセンスを選択

概要
目次

経頸部卵管滅菌。経頸部不妊手術または卵管閉塞は、女性に恒久的な避妊を提供する手順です。これは、外科的卵管結紮術に代わる非常に効果的で低侵襲の代替法です。
まとめグローバル経頸部女性の不妊手術市場は、2015年から2019年までのCAGR xx％でxxx百万米ドルと評価されました。その後、2020年にはXXX百万米ドルに達し、2020年から2025年までのCAGRはxx％になります。

世界の経頸部女性の不妊手術市場では、このレポートは特に北アメリカ、南アメリカ、ヨーロッパとアジア太平洋、および中東とアフリカに焦点を当てています。このレポートは、アプリケーション、タイプ、地域、および製造業者に基づいて市場を分類します。

メーカー別の市場細分化では、レポートは次の企業をカバーしています-
Ethicon
Medtronic
Karl Storz
Olympus
Applied Medical
Richard Wolf
Bayer AG
Stryker
B. Braun Aesculap
ERBE
LiNA Medical
ConMed
Microline Surgical
Apollo Endosurgery

地理的地域による市場細分化では、レポートは次の地域を分析しました-
北米（米国、カナダ、メキシコ）
ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
アジア太平洋（中国、日本、韓国、インド、東南アジア）
南アメリカ（ブラジル、アルゼンチン、コロンビアなど）
中東およびアフリカ（サウジアラビア、アラブ首長国連邦、エジプト、ナイジェリア、南アフリカ）

タイプによる市場細分化：
卵管結紮
経インプラント
アプリケーションによる市場細分化：
病院
診療所
この調査は、次の重要な質問に対する回答を提供します。
• 2020年から2025年の予測期間における経頸部女性の不妊手術市場の推定成長率と市場シェアおよび規模はどのくらいですか？
• 予測期間2020年から2025年の経頸部女性の不妊手術市場の原動力は何ですか？
• 著名なマーケットプレーヤーは誰ですか？彼らは他の競合他社に対してどのように競争力を獲得しましたか？
• 世界中の経頸部女性の不妊手術の業界の進歩に影響を与える市場動向は何ですか？
• 業界の進歩を制限する主な課題と脅威は何ですか？
• 市場は著名な市場プレーヤーにとってどのような機会を持っていますか？
このレポートに関する特別な要件がある場合は、お知らせください。カスタムレポートを提供できます。

注–より正確な市場予測を提供するために、COVID-19の影響を考慮して、すべてのレポートが配信前に更新されます。

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Transcervical Female Sterilization Market Size Growth Rate by Type (2020-2025)
1.3.2 Tubal Ligation
1.3.3 Transcervical Implant
1.4 Market Segment by Application
1.4.1 Global Transcervical Female Sterilization Market Share by Application (2020-2025)
1.4.2 Hospital
1.4.3 Clinic
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Transcervical Female Sterilization Production Value 2015-2025
2.1.2 Global Transcervical Female Sterilization Production 2015-2025
2.1.3 Global Transcervical Female Sterilization Capacity 2015-2025
2.1.4 Global Transcervical Female Sterilization Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2020-2025
2.2.1 Global Transcervical Female Sterilization Market Size CAGR of Key Regions
2.2.2 Global Transcervical Female Sterilization Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Transcervical Female Sterilization Capacity by Manufacturers
3.1.2 Global Transcervical Female Sterilization Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Transcervical Female Sterilization Revenue by Manufacturers (2015-2019)
3.2.2 Transcervical Female Sterilization Revenue Share by Manufacturers (2015-2019)
3.2.3 Global Transcervical Female Sterilization Market Concentration Ratio (CR5 and HHI)
3.3 Transcervical Female Sterilization Price by Manufacturers
3.4 Key Manufacturers Transcervical Female Sterilization Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Transcervical Female Sterilization Market
3.6 Key Manufacturers Transcervical Female Sterilization Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Tubal Ligation Production and Production Value (2015-2019)
4.1.2 Transcervical Implant Production and Production Value (2015-2019)
4.2 Global Transcervical Female Sterilization Production Market Share by Type
4.3 Global Transcervical Female Sterilization Production Value Market Share by Type
4.4 Transcervical Female Sterilization Ex-factory Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Transcervical Female Sterilization Consumption by Application

6 Production by Regions
6.1 Global Transcervical Female Sterilization Production (History Data) by Regions 2015-2019
6.2 Global Transcervical Female Sterilization Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Transcervical Female Sterilization Production Growth Rate 2015-2019
6.3.2 United States Transcervical Female Sterilization Production Value Growth Rate 2015-2019
6.3.3 Key Players in United States
6.3.4 United States Transcervical Female Sterilization Import & Export
6.4 European Union
6.4.1 European Union Transcervical Female Sterilization Production Growth Rate 2015-2019
6.4.2 European Union Transcervical Female Sterilization Production Value Growth Rate 2015-2019
6.4.3 Key Players in European Union
6.4.4 European Union Transcervical Female Sterilization Import & Export
6.5 China
6.5.1 China Transcervical Female Sterilization Production Growth Rate 2015-2019
6.5.2 China Transcervical Female Sterilization Production Value Growth Rate 2015-2019
6.5.3 Key Players in China
6.5.4 China Transcervical Female Sterilization Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia

7 Transcervical Female Sterilization Consumption by Regions
7.1 Global Transcervical Female Sterilization Consumption (History Data) by Regions
7.2 United States
7.2.1 United States Transcervical Female Sterilization Consumption by Type
7.2.2 United States Transcervical Female Sterilization Consumption by Application
7.3 European Union
7.3.1 European Union Transcervical Female Sterilization Consumption by Type
7.3.2 European Union Transcervical Female Sterilization Consumption by Application
7.4 China
7.4.1 China Transcervical Female Sterilization Consumption by Type
7.4.2 China Transcervical Female Sterilization Consumption by Application
7.5 Rest of World
7.5.1 Rest of World Transcervical Female Sterilization Consumption by Type
7.5.2 Rest of World Transcervical Female Sterilization Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia

8 Company Profiles
8.1 Ethicon
8.1.1 Ethicon Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Transcervical Female Sterilization
8.1.4 Transcervical Female Sterilization Product Introduction
8.1.5 Ethicon Recent Development
8.2 Medtronic
8.2.1 Medtronic Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Transcervical Female Sterilization
8.2.4 Transcervical Female Sterilization Product Introduction
8.2.5 Medtronic Recent Development
8.3 Karl Storz
8.3.1 Karl Storz Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Transcervical Female Sterilization
8.3.4 Transcervical Female Sterilization Product Introduction
8.3.5 Karl Storz Recent Development
8.4 Olympus
8.4.1 Olympus Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Transcervical Female Sterilization
8.4.4 Transcervical Female Sterilization Product Introduction
8.4.5 Olympus Recent Development
8.5 Applied Medical
8.5.1 Applied Medical Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Transcervical Female Sterilization
8.5.4 Transcervical Female Sterilization Product Introduction
8.5.5 Applied Medical Recent Development
8.6 Richard Wolf
8.6.1 Richard Wolf Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Transcervical Female Sterilization
8.6.4 Transcervical Female Sterilization Product Introduction
8.6.5 Richard Wolf Recent Development
8.7 Bayer AG
8.7.1 Bayer AG Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Transcervical Female Sterilization
8.7.4 Transcervical Female Sterilization Product Introduction
8.7.5 Bayer AG Recent Development
8.8 Stryker
8.8.1 Stryker Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Transcervical Female Sterilization
8.8.4 Transcervical Female Sterilization Product Introduction
8.8.5 Stryker Recent Development
8.9 B. Braun Aesculap
8.9.1 B. Braun Aesculap Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Transcervical Female Sterilization
8.9.4 Transcervical Female Sterilization Product Introduction
8.9.5 B. Braun Aesculap Recent Development
8.10 ERBE
8.10.1 ERBE Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Transcervical Female Sterilization
8.10.4 Transcervical Female Sterilization Product Introduction
8.10.5 ERBE Recent Development
8.11 LiNA Medical
8.12 ConMed
8.13 Microline Surgical
8.14 Apollo Endosurgery

9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global Transcervical Female Sterilization Capacity, Production Forecast 2020-2025
9.1.2 Global Transcervical Female Sterilization Production Value Forecast 2020-2025
9.2 Market Forecast by Regions
9.2.1 Global Transcervical Female Sterilization Production and Value Forecast by Regions 2020-2025
9.2.2 Global Transcervical Female Sterilization Consumption Forecast by Regions 2020-2025
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global Transcervical Female Sterilization Production Forecast by Type
9.7.2 Global Transcervical Female Sterilization Production Value Forecast by Type
9.8 Consumption Forecast by Application

10 Value Chain and Sales Channels Analysis
10.1 Value Chain Analysis
10.2 Sales Channels Analysis
10.2.1 Transcervical Female Sterilization Sales Channels
10.2.2 Transcervical Female Sterilization Distributors
10.3 Transcervical Female Sterilization Customers

11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porter\'s Five Forces Analysis

12 Key Findings

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer